SEHK:883
SEHK:883Oil and Gas

CNOOC (SEHK:883) Valuation Check After New Weizhou 11-4 Offshore Project Starts Production

CNOOC (SEHK:883) just brought its Weizhou 11-4 adjustment and satellite fields online in the Beibu Gulf, a fresh production boost built around new wells and coordinated offshore processing capacity. See our latest analysis for CNOOC. That fresh output story seems to be feeding into sentiment, with the share price up 4.25% over the past month and a 1 year total shareholder return of roughly 34 percent underscoring still solid momentum. If CNOOC’s latest production ramp up has you thinking...
SEHK:6990
SEHK:6990Biotechs

Is Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Fairly Valued After Its 175% Year-To-Date Share Price Surge?

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has quietly been on a strong run this year, with the stock up around 175% year to date and roughly 150% over the past year. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. That kind of year to date share price return, combined with a 1 year total shareholder return of roughly 150 percent, signals that sentiment has swung sharply toward Kelun Biotech as investors price in faster growth and a lower perceived risk...
SEHK:1208
SEHK:1208Metals and Mining

Will MMG (SEHK:1208)'s Leadership Reshuffle Subtly Recast Its Governance And Risk Narrative?

MMG Limited recently reshaped its leadership structure, appointing Cao Liang as Chairman, expanding executive roles including a new COO, and formalising a refreshed board and committee line-up to align with updated corporate governance requirements. The creation of a Lead Independent Non-Executive Director role and elevation of regional presidents to the Executive Committee point to a stronger focus on board oversight and operational accountability across key assets such as Las Bambas and...
SEHK:806
SEHK:806Capital Markets

Asian Penny Stocks To Watch In December 2025

As global markets keenly await the final Federal Reserve meeting of the year, Asian markets are navigating a landscape marked by mixed economic signals and cautious optimism. Amid these conditions, penny stocks—often smaller or newer companies with potential for significant growth—continue to capture investor interest due to their affordability and growth prospects. While the term 'penny stocks' might seem outdated, these investments can still represent valuable opportunities when backed by...
SEHK:2013
SEHK:2013Software

Weimob (SEHK:2013) Valuation After CEO’s AI-Focused Share Purchase and New Incentive Plans

Weimob (SEHK:2013) just saw its chairman and CEO, Sun Taoyong, scoop up another 1,534,000 shares. This move puts real money behind the company’s AI focused strategy and recent incentive plans. See our latest analysis for Weimob. That confidence comes after a tough stretch, with Weimob’s share price down 40.18 percent year to date and a 90 day share price return of minus 17.84 percent, even as the 1 year total shareholder return is a positive 21.47 percent. This suggests recent insider buying...
SEHK:2007
SEHK:2007Real Estate

Assessing Country Garden (SEHK:2007) Valuation After Court‑Backed Debt Restructuring Milestone

Country Garden Holdings (SEHK:2007) just cleared a major hurdle in its turnaround, with a court sanctioned offshore debt restructuring scheme and bondholder approved changes to several onshore bonds reshaping its capital structure. See our latest analysis for Country Garden Holdings. Investors have welcomed this progress, with a recent 1 day share price return of 1.96 percent suggesting sentiment is improving. However, a deeply negative 3 year total shareholder return of 83.01 percent shows...
SEHK:1339
SEHK:1339Insurance

PICC Group (SEHK:1339) Valuation Check After Rumor‑Driven Volatility and Executive Clarification

People's Insurance Company Group of China SEHK:1339 is back in the spotlight after its PICC Property and Casualty unit addressed market rumors about senior executives, stating that operations remain normal despite the recent rumor driven share price swings. See our latest analysis for People's Insurance Company (Group) of China. The clarification from PICC P&C comes after a rumor driven spike in volatility, with the share price now at HK$7.01. This builds on a strong year to date 90.49...
SEHK:1877
SEHK:1877Biotechs

Shanghai Junshi Biosciences (SEHK:1877): Reassessing Valuation After a Sharp Pullback and Strong Year-to-Date Rally

Shanghai Junshi Biosciences (SEHK:1877) has quietly pulled back after a strong year to date, and that dip is starting to catch investors’ attention as they reassess the biotech’s growth profile and risks. See our latest analysis for Shanghai Junshi Biosciences. Despite the recent pullback, Shanghai Junshi Biosciences is still sitting on a strong year to date share price return. This suggests that earlier optimism about its drug pipeline and earnings trajectory is now cooling as investors...
SEHK:3900
SEHK:3900Real Estate

Greentown China Holdings (SEHK:3900): Valuation Check After Robust Unaudited Operating Update and Sentiment Shift

Greentown China Holdings (SEHK:3900) just released unaudited operating data for the eleven months to November 2025, showing sizeable contracted sales and healthy sales area across both self investment and project management projects. See our latest analysis for Greentown China Holdings. The latest operating update seems to be nudging sentiment in the right direction, with a roughly 10 percent 1 month share price return contrasting with a still negative 1 year total shareholder return. This...
SEHK:966
SEHK:966Insurance

China Taiping (SEHK:966): Valuation Check After Hong Kong Fire Puts Insurance Exposure in Focus

A deadly fire that tore through seven high rise towers in Hong Kong has put China Taiping Insurance Holdings (SEHK:966) under a harsh spotlight, as its local affiliate faces over $200 million in claims. See our latest analysis for China Taiping Insurance Holdings. Despite the tragic fire highlighting near term earnings risk, investors have largely looked through the shock. The share price is up 7.1 percent over one day and has delivered a powerful 67.4 percent year to date share price return,...
SEHK:177
SEHK:177Infrastructure

How Investors Are Reacting To Jiangsu Expressway (SEHK:177) Abolishing Its Supervisory Committee And Revamping Governance

Jiangsu Expressway Company Limited has announced plans, ahead of its 18 December 2025 EGM, to abolish its Supervisory Committee and amend its Articles of Association, marking a significant shift in its corporate governance structure. This move is drawing attention because reconfiguring oversight mechanisms can alter how investors assess accountability, control, and long‑term governance quality at the company. We will now examine how the proposed abolition of the Supervisory Committee could...
SEHK:489
SEHK:489Auto

The Bull Case For Dongfeng Motor Group (SEHK:489) Could Change Following Renewed VOYAH Spin-off Focus - Learn Why

Recent coverage highlighted that Dongfeng Motor Group continues to own 100% of Hong Kong-based EV subsidiary VOYAH, as investors revisit its potential spin-off amid active spin-off interest in the Hong Kong market. The discussion of VOYAH’s standalone valuation, competitive position in China’s crowded EV sector, and Hong Kong listing rules offers fresh insight into how a spin-off could reshape Dongfeng’s business profile. We will now examine how the renewed focus on a possible VOYAH spin-off...
SEHK:3933
SEHK:3933Pharmaceuticals

The Bull Case For United Laboratories International Holdings (SEHK:3933) Could Change Following Key Cefoperazone-Sulbactam Approval

United Laboratories International Holdings recently reported that its wholly owned Zhongshan branch of Zhuhai United Laboratories received China National Medical Products Administration approval, with quality and efficacy consistency evaluation, for its 2.0g Cefoperazone Sodium and Sulbactam Sodium for Injection, already classified as a Category B drug in the 2024 National Medical Insurance Drug List. This outcome strengthens the company’s anti-infective portfolio by validating a...
SEHK:290
SEHK:290Capital Markets

GoFintech Quantum Innovation (SEHK:290): Valuation Check After Swinging From Loss to Half-Year Profit

GoFintech Quantum Innovation (SEHK:290) just flipped its half year results from a small loss to a net profit, and that earnings swing is quickly becoming the main story behind the stock’s recent momentum. See our latest analysis for GoFintech Quantum Innovation. That earnings swing helps explain why the share price has climbed to HK$2.29, with a powerful year to date share price return of 186.25% and a remarkable three year total shareholder return of 1,599.01%, suggesting momentum is still...
SEHK:1810
SEHK:1810Tech

Xiaomi (SEHK:1810) Valuation Check After Record Q3 and 199% Smart EV Revenue Surge

Xiaomi (SEHK:1810) just posted a standout third quarter, with several metrics hitting record highs and its Cars unit delivering a breakthrough as smart electric vehicle and innovation revenue surged more than 199% year over year. See our latest analysis for Xiaomi. The upbeat quarter has helped Xiaomi regain some investor confidence, with the latest HK$42.78 share price sitting against a solid year to date share price return. A powerful three year total shareholder return above 270% suggests...
SEHK:17
SEHK:17Real Estate

New World Development (SEHK:17): Reassessing Valuation After Major Debt Exchange and Sharp Balance Sheet Deleveraging

New World Development (SEHK:17) has just wrapped up a major debt exchange, issuing about USD 1.36 billion in new bonds and cutting its debt load by nearly 50%, a meaningful shift for equity holders. See our latest analysis for New World Development. The sizeable debt cut seems to have given sentiment a lift, with a 1 day share price return of 4.87% helping extend its year to date share price return of 41.07%. However, the 3 year total shareholder return is still deeply negative at 62.10%. If...